|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash and cash equivalents | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Deferred commissions, current | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Property and equipment, net | |||||
| Operating lease right-of-use asset | |||||
| Deferred commissions, non-current | |||||
| Intangible assets, net | |||||
| Goodwill | |||||
| Other assets | |||||
| Total assets | |||||
| Liabilities and stockholders’ equity | |||||
| Current liabilities | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liability, current | |||||
| Deferred revenue | |||||
| Total current liabilities | |||||
| Long term debt | |||||
| Warrant liabilities, non-current | |||||
| Other liabilities, non-current | |||||
| Total liabilities | |||||
| Redeemable convertible preferred stock, $0.001 par value per share; no shares and 120,689 shares authorized as of December 31, 2025 and December 31, 2024, respectively; no shares and 118,219 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively; aggregate liquidation preference of $0 and $455,588 as of December 31, 2025 and December 31, 2024, net of issuance costs | |||||
| Stockholders’ equity | |||||
| Common stock, $0.001 par value per share; 750,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 60,607 and 58,429 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total stockholders’ equity | |||||
| Total liabilities and stockholders’ equity |
Loading...
